chr12-102958393-CGCA-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_004316.4(ASCL1):βc.184_186delβ(p.Gln62del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.024 in 1,297,614 control chromosomes in the GnomAD database, including 46 homozygotes. Variant has been reported in ClinVar as Likely benign (β ).
Frequency
Genomes: π 0.011 ( 7 hom., cov: 0)
Exomes π: 0.026 ( 39 hom. )
Consequence
ASCL1
NM_004316.4 inframe_deletion
NM_004316.4 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.219
Genes affected
ASCL1 (HGNC:738): (achaete-scute family bHLH transcription factor 1) This gene encodes a member of the basic helix-loop-helix (BHLH) family of transcription factors. The protein activates transcription by binding to the E box (5'-CANNTG-3'). Dimerization with other BHLH proteins is required for efficient DNA binding. This protein plays a role in the neuronal commitment and differentiation and in the generation of olfactory and autonomic neurons. Mutations in this gene may contribute to the congenital central hypoventilation syndrome (CCHS) phenotype in rare cases. [provided by RefSeq, Jul 2008]
PAH (HGNC:8582): (phenylalanine hydroxylase) This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 12-102958393-CGCA-C is Benign according to our data. Variant chr12-102958393-CGCA-C is described in ClinVar as [Likely_benign]. Clinvar id is 227179.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr12-102958393-CGCA-C is described in Lovd as [Benign]. Variant chr12-102958393-CGCA-C is described in Lovd as [Benign].
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0789 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ASCL1 | NM_004316.4 | c.184_186del | p.Gln62del | inframe_deletion | 1/2 | ENST00000266744.4 | |
PAH | NM_001354304.2 | c.-297_-295del | 5_prime_UTR_variant | 1/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ASCL1 | ENST00000266744.4 | c.184_186del | p.Gln62del | inframe_deletion | 1/2 | 1 | NM_004316.4 | P1 | |
PAH | ENST00000547319.1 | n.15_17del | non_coding_transcript_exon_variant | 1/3 | 4 | ||||
PAH | ENST00000551337.5 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1587AN: 149932Hom.: 7 Cov.: 0
GnomAD3 genomes
AF:
AC:
1587
AN:
149932
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0257 AC: 29494AN: 1147600Hom.: 39 AF XY: 0.0276 AC XY: 15525AN XY: 562096
GnomAD4 exome
AF:
AC:
29494
AN:
1147600
Hom.:
AF XY:
AC XY:
15525
AN XY:
562096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0106 AC: 1589AN: 150014Hom.: 7 Cov.: 0 AF XY: 0.0113 AC XY: 831AN XY: 73218
GnomAD4 genome
AF:
AC:
1589
AN:
150014
Hom.:
Cov.:
0
AF XY:
AC XY:
831
AN XY:
73218
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 25, 2014 | Gln51[11] in exon 1 of ASCL1: This variant is not expected to have clinical sign ificance because it has been identified in 2.2% (7/322) of Caucasian control chr omosomes (Deng 2010) and has been identified by our laboratory in 1.6% (5/304) o f Caucasian control chromosomes. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at